• English
    • العربية
  • العربية
  • Login
  • QU
  • QU Library
  •  Home
  • Communities & Collections
  • Help
    • Item Submission
    • Publisher policies
    • User guides
    • FAQs
  • About QSpace
    • Vision & Mission
View Item 
  •   Qatar University Digital Hub
  • Qatar University Institutional Repository
  • Academic
  • Faculty Contributions
  • College of Pharmacy
  • Pharmacy Research
  • View Item
  • Qatar University Digital Hub
  • Qatar University Institutional Repository
  • Academic
  • Faculty Contributions
  • College of Pharmacy
  • Pharmacy Research
  • View Item
  •      
  •  
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study

    Thumbnail
    View/Open
    Publisher version (You have accessOpen AccessIcon)
    Publisher version (Check access options)
    Check access options
    Open Access Version of Record (761.5Kb)
    Date
    2013-08
    Author
    Perera, Minoli A
    Cavallari, Larisa H
    Limdi, Nita A
    Gamazon, Eric R
    Konkashbaev, Anuar
    Daneshjou, Roxana
    Pluzhnikov, Anna
    Crawford, Dana C
    Wang, Jelai
    Liu, Nianjun
    Tatonetti, Nicholas
    Bourgeois, Stephane
    Takahashi, Harumi
    Bradford, Yukiko
    Burkley, Benjamin M
    Desnick, Robert J
    Halperin, Jonathan L
    Khalifa, Sherief I
    Langaee, Taimour Y
    Lubitz, Steven A
    Nutescu, Edith A
    Oetjens, Matthew
    Shahin, Mohamed H
    Patel, Shitalben R
    Sagreiya, Hersh
    Tector, Matthew
    Weck, Karen E
    Rieder, Mark J
    Scott, Stuart A
    Wu, Alan HB
    Burmester, James K
    Wadelius, Mia
    Deloukas, Panos
    Wagner, Michael J
    Mushiroda, Taisei
    Kubo, Michiaki
    Roden, Dan M
    Cox, Nancy J
    Altman, Russ B
    Klein, Teri E
    Nakamura, Yusuke
    Johnson, Julie A
    ...show more authors ...show less authors
    Metadata
    Show full item record
    Abstract
    Summary BackgroundVKORC1 and CYP2C9 are important contributors to warfarin dose variability, but explain less variability for individuals of African descent than for those of European or Asian descent. We aimed to identify additional variants contributing to warfarin dose requirements in African Americans. MethodsWe did a genome-wide association study of discovery and replication cohorts. Samples from African-American adults (aged ≥18 years) who were taking a stable maintenance dose of warfarin were obtained at International Warfarin Pharmacogenetics Consortium (IWPC) sites and the University of Alabama at Birmingham (Birmingham, AL, USA). Patients enrolled at IWPC sites but who were not used for discovery made up the independent replication cohort. All participants were genotyped. We did a stepwise conditional analysis, conditioning first for VKORC1 −1639G→A, followed by the composite genotype of CYP2C9*2 and CYP2C9*3. We prespecified a genome-wide significance threshold of p<5×10−8 in the discovery cohort and p<0·0038 in the replication cohort. FindingsThe discovery cohort contained 533 participants and the replication cohort 432 participants. After the prespecified conditioning in the discovery cohort, we identified an association between a novel single nucleotide polymorphism in the CYP2C cluster on chromosome 10 (rs12777823) and warfarin dose requirement that reached genome-wide significance (p=1·51×10−8). This association was confirmed in the replication cohort (p=5·04×10−5); analysis of the two cohorts together produced a p value of 4·5×10−12. Individuals heterozygous for the rs12777823 A allele need a dose reduction of 6·92 mg/week and those homozygous 9·34 mg/week. Regression analysis showed that the inclusion of rs12777823 significantly improves warfarin dose variability explained by the IWPC dosing algorithm (21% relative improvement). InterpretationA novel CYP2C single nucleotide polymorphism exerts a clinically relevant effect on warfarin dose in African Americans, independent of CYP2C9*2 and CYP2C9*3. Incorporation of this variant into pharmacogenetic dosing algorithms could improve warfarin dose prediction in this population. FundingNational Institutes of Health, American Heart Association, Howard Hughes Medical Institute, Wisconsin Network for Health Research, and the Wellcome Trust.
    URI
    http://www.sciencedirect.com/science/article/pii/S0140673613606819
    DOI/handle
    http://dx.doi.org/10.1016/S0140-6736(13)60681-9
    http://hdl.handle.net/10576/4763
    Collections
    • Pharmacy Research [‎1426‎ items ]

    entitlement


    Qatar University Digital Hub is a digital collection operated and maintained by the Qatar University Library and supported by the ITS department

    Contact Us | Send Feedback
    Contact Us | Send Feedback | QU

     

     

    Home

    Submit your QU affiliated work

    Browse

    All of Digital Hub
      Communities & Collections Publication Date Author Title Subject Type Language Publisher
    This Collection
      Publication Date Author Title Subject Type Language Publisher

    My Account

    Login

    Statistics

    View Usage Statistics

    About QSpace

    Vision & Mission

    Help

    Item Submission Publisher policiesUser guides FAQs

    Qatar University Digital Hub is a digital collection operated and maintained by the Qatar University Library and supported by the ITS department

    Contact Us | Send Feedback
    Contact Us | Send Feedback | QU

     

     

    Video